TradeLink Capital’s Pfizer PFE Stock Holding History

TradeLink Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-12,732	Closed	-$395K	–	42
2020 Q2	$395K	Buy	+12,732	New	+$433K	1.64%	23
2018 Q3	–	Sell	-12,543	Closed	-$432K	–	38
2018 Q2	$432K	Buy	+12,543	New	+$429K	2.08%	12
2015 Q1	–	Sell	-864	Closed	-$26K	–	288
2014 Q4	$26K	Sell	864 -928	-52%	-$26.6K	0.03%	394
2014 Q3	$50K	Sell	1,792 -20,764	-92%	-$583K	0.08%	188
2014 Q2	$635K	Buy	+22,556	New	+$643K	0.58%	18
2013 Q4	–	Sell	-2,740	Closed	-$75K	–	254
2013 Q3	$75K	Sell	2,740 -3,159,260	-100%	-$86M	0.17%	167
2013 Q2	$84M	Buy	+3,162,000	New	+$87.4M	25.97%	1

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

TradeLink Capital's PFE Position: Q3 2020 in Review

TradeLink Capital sold out of Pfizer (PFE) in Q3 2020, closing a stake of 12,732 shares — an estimated $395K sold.

TradeLink Capital first reported a position in PFE in Q2 2013 and held it in 7 quarters. The position peaked at $84M in Q2 2013. 2,508 funds tracked by Wall St. Rank hold PFE as of Q3 2020.

TradeLink Capital reported no remaining Pfizer position as of Q3 2020 after selling out during the quarter.
TradeLink Capital sold 12,732 Pfizer shares in Q3 2020, an estimated $395K.
TradeLink Capital first reported a position in Pfizer in Q2 2013 and held it in 7 quarters.
TradeLink Capital's Pfizer position peaked at $84M in Q2 2013.
2,508 funds tracked by Wall St. Rank held Pfizer as of Q3 2020.

Based on TradeLink Capital's 13F filing for Q3 2020, filed 2 Nov 2020.